These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 16378195)
1. Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model. Hribaschek A; Kuhn R; Pross M; Meyer F; Fahlke J; Ridwelski K; Boltze C; Lippert H Surg Today; 2006; 36(1):57-62. PubMed ID: 16378195 [TBL] [Abstract][Full Text] [Related]
2. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis]. Hribaschek A; Pross M; Ridwelski K; Meyer F; Fenske A; Krüger S; Lippert H Zentralbl Chir; 2004 Aug; 129(4):328-34. PubMed ID: 15354258 [TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of peritoneal carcinomatosis in experimental investigations with CPT-11 and oxaliplatin. Hribaschek A; Pross M; Kuhn R; Krüger S; Ridwelski K; Halangk W; Boltze C; Lippert H Anticancer Drugs; 2002 Jul; 13(6):605-14. PubMed ID: 12172506 [TBL] [Abstract][Full Text] [Related]
4. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis. Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000 [TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode. Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689 [TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model. Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698 [TBL] [Abstract][Full Text] [Related]
7. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis]. Maruyama M; Nagahama T; Ebuchi M; Yuasa Y Gan To Kagaku Ryoho; 2000 Oct; 27(12):1855-7. PubMed ID: 11086429 [TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study. Li PC; Chen LD; Zheng F; Li Y J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213 [TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis. Maruyama M; Nagahama T; Yuasa Y Anticancer Res; 1999; 19(5B):4187-91. PubMed ID: 10628373 [TBL] [Abstract][Full Text] [Related]
10. Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding. Choi MK; Ahn BJ; Yim DS; Park YS; Kim S; Sohn TS; Noh JH; Heo JS; Lee J; Park SH; Park JO; Lim HY; Kang WK Cancer Chemother Pharmacol; 2011 Jan; 67(1):5-11. PubMed ID: 20213078 [TBL] [Abstract][Full Text] [Related]
11. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis]. Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K Gan To Kagaku Ryoho; 2003 Oct; 30(11):1602-4. PubMed ID: 14619474 [TBL] [Abstract][Full Text] [Related]
12. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis. Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intraperitoneal irinotecan in a pig model. Turcotte S; Sideris L; Younan R; Drolet P; Dubé P J Surg Oncol; 2010 Jun; 101(7):637-42. PubMed ID: 20461774 [TBL] [Abstract][Full Text] [Related]
14. [Antitumor activity of CPT-11 against rat Walker 256 carcinoma]. Furuta T; Yokokura T; Mutai M Gan To Kagaku Ryoho; 1988 Sep; 15(9):2757-60. PubMed ID: 3415271 [TBL] [Abstract][Full Text] [Related]
15. [Liver concentration of CPT-11, SN-38 and SN-38 GLU in intraperitoneal and intravenous administration of CPT-11]. Maruyama M; Nagahama T; Yuasa Y Gan To Kagaku Ryoho; 1999 Oct; 26(12):1967-9. PubMed ID: 10560438 [TBL] [Abstract][Full Text] [Related]
16. Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice. Dai M; Xu X; Song J; Fu S; Gou M; Luo F; Qian Z Cancer Lett; 2011 Dec; 312(2):189-96. PubMed ID: 21943824 [TBL] [Abstract][Full Text] [Related]
17. [Experimental study on CPT-11 intraperitoneal chemotherapy--metabolism of CPT-11 in malignant ascites]. Maruyama M; Toukairin Y; Baba H; Yoshida T; Kure N; Nagahama T; Ebuchi M Gan To Kagaku Ryoho; 2000 Oct; 27(12):1858-60. PubMed ID: 11086430 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic study of the intraperitoneal administration of CPT-11 for patients with peritoneal seedings of gastric and colonic cancers]. Maruyama M; Toukairin Y; Baba H; Kure N; Nagahama T; Ebuchi M Gan To Kagaku Ryoho; 2001 Oct; 28(11):1505-7. PubMed ID: 11707965 [TBL] [Abstract][Full Text] [Related]
19. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations. Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796 [TBL] [Abstract][Full Text] [Related]
20. Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: biodegradable microsphere in thermosensitive hydrogel. Liu L; Wu Q; Ma X; Xiong D; Gong C; Qian Z; Zhao X; Wei Y Colloids Surf B Biointerfaces; 2013 Jun; 106():93-101. PubMed ID: 23434697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]